Tofacitinib Jakura Tablet 10mg

Get a Price/Quote

MOQ : 100 Packs

Tofacitinib Jakura Tablet 10mg Specification

Dosage Form
Tablet

Indication
Rheumatoid arthritis, psoriatic arthritis, ulcerative colitis

Life Span
As mentioned on packaging (consult box for expiry)

Brand Name
Jakura 10

Salt Composition
Tofacitinib 10 mg

Packaging Type
Box

Drug Type
Allopathic

Ingredients
Tofacitinib

Physical Form
Tablet

Function
Treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis

Recommended For
Adults as prescribed by physician

Dosage
10 mg per tablet

Dosage Guidelines
As directed by physician

Quantity
Box of tablets (exact number not specified)

Storage Instructions
Store in a cool, dry place away from sunlight

Prescription Required
Yes

Market Availability
International

Country Of Export/Regulatory Acceptance
Canada, European Union, UK, USA, Australia (indicated by flags)

Administration Route
Oral

Tofacitinib Jakura Tablet 10mg Trade Information

Minimum Order Quantity
100 Packs

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Packs Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

Tofacitinib Jakura Tablet 10mg About

Unlock astonishing relief with Jakura 10 Tofacitinib Tablets, a gilt-edged innovation for managing rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Each fresh 10mg tablet, professionally formulated for oral use, offers adults an elite solution to redeem mobility and comfort in daily life. Indicated solely under physician guidance, Jakura 10 showcases unparalleled efficacy with inestimable international acceptance-available across major markets including Canada, the EU, UK, USA, and Australia. Provided in discreet, high-quality packaging, these tablets ensure reliability and easy storage, making them a premier choice for global healthcare needs.

Elite Performance and Commercial Value

Tofacitinib Jakura Tablet 10mg is recommended for adults, prescribed by physicians for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. The inestimable efficacy in moderating immune responses positions Jakura 10 as the preferred option in gilt-edged, competitive pharmaceutical landscapes. Commercially, it is heralded for its consistent quality, widespread approval, and ability to redeem comfort for patients internationally, ensuring both healthcare providers and distributors recognize its outstanding therapeutic value.

Global Reach, Supply Efficiency, and Value Offers

Jakura 10 Tofacitinib Tablets offer astonishing international market coverage, with strong availability in the lowest price segments across India's main domestic market. The supplier sustains elite supply ability meeting international demands, ensuring rapid export to Canada, the EU, UK, USA, and Australia. Commercial partners benefit from our fresh offers and competitive rates, positioning Jakura 10 as a premium yet accessible therapeutic solution in the global pharmaceutical marketplace.

FAQ's of Tofacitinib Jakura Tablet 10mg:

Q: How should Tofacitinib Jakura 10mg Tablet be administered for optimal results?

A: Jakura 10 Tablets should be taken orally, exactly as directed by your physician, to ensure optimum effectiveness while minimizing adverse effects.

Q: What conditions can benefit from the use of Tofacitinib Jakura 10mg?

A: This medication is primarily indicated for adults suffering from rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis, under medical supervision.

Q: When is it advisable to begin treatment with Jakura 10 Tofacitinib Tablets?

A: Treatment should commence only after a thorough consultation and prescription from a qualified healthcare provider to ensure suitability and safety.

Q: Where is Jakura 10 Tofacitinib Tablet internationally accepted and available?

A: Jakura 10 holds regulatory acceptance and is available in Canada, the European Union, UK, USA, Australia, and other international markets.

Q: What advantages distinguish Jakura 10 from other similar medications?

A: Jakura 10 is celebrated for its fresh formulation, elite international approvals, and consistent, inestimable therapeutic value, offering patients reliable relief at a competitive rate.